Neuroprotection and traumatic brain injury: The search continues

Archives of Neurology

Volumn 58, Issue 10, 2001, Pages 1553-1555

  Faden, Alan I ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; BARBITURIC ACID DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; DEXANABINOL; GLUTAMATE RECEPTOR ANTAGONIST; MAGNESIUM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROPROTECTIVE AGENT; NIMODIPINE; PROTIRELIN DERIVATIVE; SCAVENGER;

ARTICLE; BRAIN INJURY; BRAIN PROTECTION; CLINICAL STUDY; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFECT; EXPERIMENTAL MODEL; HUMAN; METHODOLOGY; NEUROPHARMACOLOGY; NONHUMAN; PRIORITY JOURNAL; TIME;

EID: 0034787937     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.58.10.1553     Document Type: Article

References (21)

1. Biochemical changes and secondary injury from stroke and trauma
2. Neurochemical sequelae of traumatic brain injury: Therapeutic implications
3. Pharmacological treatment of central nervous system trauma
4. Novel pharmacologic strategies in the treatment of experimental traumatic brain injury: 1998
5. Pharmacologic treatment of acute traumatic brain injury
6. Current status of neuroprotection trials for traumatic brain injury: Lessons from animal models and clinical studies
7. An overview of brain injury models
8. The role of glutamate receptors in the pathophysiology of traumatic brain injury
9. Activation of CPP32-like caspases contributes to neuronal apoptosis and neurological dysfunction after traumatic brain injury
10. Evidence of apoptotic cell death after experimental traumatic brain injury in the rat
11. The role of excitatory amino acids and NMDA receptors in traumatic brain injury
12. Comparison of single and combination drug treatment strategies in experimental brain trauma
13. Development of HU-211 as a neuroprotectant for ischemic brain damage
14. Effects of pegorgotein on neurologic outcome of patients with severe head injury: A multicenter, randomized controlled trial
15. Failure of the competitive N-methyl-D-aspartate antagonist Selfotel (CGS 19755) in the treatment of severe head injury: Results of two phase III clinical trials
16. The effect of nimodipine on outcome after head injury: A prospective randomised control trial: The British/Finnish Co-operative Head Injury Trial group
17. A multicenter trial of the efficacy of nimodipine on outcome after severe head injury
18. Traumatic subarachnoid hemorrhage and its treatment with nimodipine
19. N-Methyl-D-aspartate antagonists and apoptotic cell death triggered by head trauma in developing rat brain
20. Combined mechanical trauma and metabolic impairment in vitro induces NMDA receptor-dependent neuronal cell death and caspase-3-dependent apoptosis
21. Size and quality of randomised controlled trials in head injury: Review of published studies